Healthcare >> Analyst Interviews >> March 29, 1999
ALEXANDER K. ARROW is a Vice President, Research at Wedbush Morgan
Securities. Previously, he was in his general surgery residency at UCLA
Medical Center. He was associated with Arthur D. Little and Hambro
Biofinance and also spent three years in a biomaterials laboratory at
MIT designing an artificial skin device for burn patients. Dr. Arrow
received his Bachelor's degree in Physics from Cornell University, his
M.D. from Harvard Medical School, and has completed the Harvard-MIT
program in Health Sciences and Technology. He is a member of the AIMR
and the Los Angeles Society of Financial Analysts and is a level III CFA
candidate. He belongs to the Society of Biomaterials and serves on the
board of the Southern California Biomedical Council. Dr. Arrow includes
medical history, yoga and running among his personal interests. Profile
TWST: How did you come to target wound care as a niche for investmentresearch? It's not focused on by anyone else, is it?
Dr. Arrow: That's right. We may be the only sellside securities